abnormal ceramide level_Degs1<Gt(OST368559)Lex>/Degs1<+>

http://metadb.riken.jp/0012232I129S5SvEvBrdDegs1GtOST368559LexDegs1Degs1Degs1GtOST368559Lex

abnormal ceramide level_Degs1<Gt(OST368559)Lex>/Degs1<+>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• delta(4)-desaturase, sphingolipid 1
  http://metadb.riken.jp/db/mgi_rdf/MGI:1097711

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Degs1<Gt(OST368559)Lex>/Degs1<+>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Degs1<+>|Degs1<Gt(OST368559)Lex>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S5/SvEvBrd

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal ceramide level
  http://purl.obolibrary.org/obo/MP_0012232

文献

http://purl.org/net/cito/citesAsAuthority

• William L. Holland, et.al., Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance., Cell metabolism, 2007, 5
  http://rdf.ncbi.nlm.nih.gov/pubmed/17339025